Clinical trials are necessary to establish its safety, efficacy, and appropriate human dosing
Recording grip strength using a simple dynamometer or even subjective 1-10 ratings provides objective feedback
A study of more than 200,000 patients found a 22.5 times higher risk of drug-induced pancreatitis (dangerous inflammation of the pancreas)
Triple peptides for the treatment of obesity Retatrutide, a single peptide linked to a fatty diacid moiety, acts as a triple-agonist targeting three receptors: GIP, GLP-1, and glucagon
As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
Clinical Review Kevin personally reviews your information for appropriateness and safety